Ashwin Singhania

Partner/Principal, Life Sciences Strategy, EY-Parthenon, Ernst & Young LLP

20+ years of experience in life sciences advising biopharma companies to support strategic growth. Supports bringing new products to market to enhance patient care.

As a principal within Strategy and Transactions, Ashwin focuses on corporate and commercial strategy for biopharma across growth strategy, transaction support and operating model transformation. His career includes roles with large pharmaceutical organizations, specialty pharmaceuticals and pre-revenue biotechs. He also supports private equity for investments in biopharmaceutical and biopharmaceutical services. 

Our latest thinking

    Contact Ashwin